Controlled Substance Monitoring and Drugs of Abuse Testing
J9 · Effective Oct 11, 2015
37 active Medicare policies list F11.229, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 11, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of F11.229 |
|---|---|---|
| Buprenorphine (Brixadi & Sublocade) | Oct 1, 2026 | Covered |
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
J6 · Effective Dec 24, 2023
JK · Effective Dec 24, 2023
JE · Effective Jun 28, 2016
JF · Effective Jun 28, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JL · Effective Oct 1, 2024
J9 · Effective Oct 1, 2024
National · Effective Oct 1, 2024
National · Effective Nov 9, 2023
National · Effective Jun 4, 2026
J9 · Effective Jan 1, 2025
National · Effective Apr 17, 2025
J6 · Effective Apr 1, 2026
J5 · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Jun 1, 2026
National · Effective Jun 1, 2026
National · Effective Apr 16, 2026
J5 · Effective Jun 1, 2026
J6 · Effective Jun 1, 2026
J6 · Effective Oct 1, 2026